Exosomal miRNA-146a is downregulated in clear cell renal cell carcinoma patients with severe immune-related adverse events

Here we report the results of the pilot project of exosomal miRNA expression levels in clear cell renal cell carcinoma (ccRCC) patients with different clinical response to ICIs (nivolumab) and treatment related toxicity. Immune-related adverse events (irAEs) are a major cause of immune checkpoint in...

Descripción completa

Detalles Bibliográficos
Autores principales: Ivanova, E., Asadullina, D., Rakhimov, R., Izmailov, A., Izmailov, Al., Gilyazova, G., Galimov, Sh., Pavlov, V., Khusnutdinova, E., Gilyazova, I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: KeAi Publishing 2022
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263420/
https://www.ncbi.nlm.nih.gov/pubmed/35846077
http://dx.doi.org/10.1016/j.ncrna.2022.06.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263420/
https://www.ncbi.nlm.nih.gov/pubmed/35846077
http://dx.doi.org/10.1016/j.ncrna.2022.06.004

Ejemplares similares